SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Scholastic Corp. – ‘10-Q’ for 2/28/22 – ‘EX-10.1’

On:  Friday, 3/18/22, at 4:01pm ET   ·   For:  2/28/22   ·   Accession #:  866729-22-10   ·   File #:  0-19860

Previous ‘10-Q’:  ‘10-Q’ on 12/17/21 for 11/30/21   ·   Next:  ‘10-Q’ on 9/23/22 for 8/31/22   ·   Latest:  ‘10-Q’ on 3/22/24 for 2/29/24   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/18/22  Scholastic Corp.                  10-Q        2/28/22   83:8.5M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.02M 
 2: EX-10.1     Material Contract                                   HTML     49K 
 3: EX-10.2     Material Contract                                   HTML     26K 
 4: EX-10.3     Material Contract                                   HTML     30K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 7: EX-32       Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Document and Entity Information                     HTML     77K 
14: R2          Condensed Consolidated Statements of Operations     HTML     93K 
15: R3          Consolidated Statements of Comprehensive Income     HTML     52K 
                (Loss)                                                           
16: R4          Condensed Consolidated Balance Sheets               HTML    151K 
17: R5          Condensed Consolidated Balance Sheets               HTML     42K 
                (Parentheticals)                                                 
18: R6          CONSOLIDATED STATEMENTS OF CHANGES IN               HTML    125K 
                STOCKHOLDERS' EQUITY Statement                                   
19: R7          Consolidated Statements of Changes in               HTML     26K 
                Stockholders' Equity (Parenthetical)                             
20: R8          Consolidated Statements of Cash Flows               HTML    121K 
21: R9          Basis of Presentation                               HTML     41K 
22: R10         Revenues                                            HTML     93K 
23: R11         Segment Information                                 HTML     60K 
24: R12         Asset Write Down                                    HTML     25K 
25: R13         Debt                                                HTML     51K 
26: R14         Commitments and Contingencies                       HTML     27K 
27: R15         Earnings (Loss) Per Share                           HTML     49K 
28: R16         Goodwill and Other Intangibles                      HTML     60K 
29: R17         Investments                                         HTML     35K 
30: R18         Employee Benefit Plans                              HTML     66K 
31: R19         Stock-Based Compensation                            HTML     46K 
32: R20         Treasury Stock                                      HTML     30K 
33: R21         Accumulated Other Comprehensive Income (Loss)       HTML    102K 
34: R22         Fair Value Measurements                             HTML     31K 
35: R23         Income Taxes and Other Taxes                        HTML     30K 
36: R24         Derivatives and Hedging                             HTML     24K 
37: R25         Other Accrued Expenses                              HTML     39K 
38: R26         Subsequent Events                                   HTML     24K 
39: R27         Basis of Presentation (Policies)                    HTML     56K 
40: R28         Revenues (Tables)                                   HTML     79K 
41: R29         Segment Information (Tables)                        HTML     54K 
42: R30         Debt (Tables)                                       HTML     38K 
43: R31         Earnings (Loss) Per Share (Tables)                  HTML     49K 
44: R32         Goodwill and Other Intangibles (Tables)             HTML     61K 
45: R33         Investments (Tables)                                HTML     33K 
46: R34         Employee Benefit Plans (Tables)                     HTML     61K 
47: R35         Stock-Based Compensation (Tables)                   HTML     49K 
48: R36         Treasury Stock (Tables)                             HTML     29K 
49: R37         Accumulated Other Comprehensive Income (Loss)       HTML    104K 
                (Tables)                                                         
50: R38         Other Accrued Expenses (Tables)                     HTML     38K 
51: R39         Basis of Presentation - Narrative (Details)         HTML     46K 
52: R40         Revenues - Disaggregation of Revenue (Details)      HTML     48K 
53: R41         Revenues - Additional Information (Details)         HTML     28K 
54: R42         Revenues - Deferred Revenue (Details)               HTML     40K 
55: R43         Revenues - Allowance for Credit Losses (Details)    HTML     30K 
56: R44         Segment Information - Schedule of segment           HTML     52K 
                reporting information (Details)                                  
57: R45         Asset Write Down (Details)                          HTML     35K 
58: R46         Debt - Schedule of Debt (Details)                   HTML     35K 
59: R47         Debt - Narrative (Details)                          HTML    123K 
60: R48         Commitments and Contingencies (Details)             HTML     25K 
61: R49         Earnings (Loss) Per Share - Schedule of Earnings    HTML     49K 
                Per Share, Basic and Diluted (Details)                           
62: R50         Earnings (Loss) Per Share - Schedule of Options     HTML     24K 
                Outstanding (Details)                                            
63: R51         Earnings (Loss) Per Share - Narrative (Details)     HTML     28K 
64: R52         Goodwill and Other Intangibles - Schedule of        HTML     32K 
                activity in goodwill (Details)                                   
65: R53         Goodwill and Other Intangibles - Narrative          HTML     31K 
                (Details)                                                        
66: R54         Goodwill and Other Intangibles - Schedule of other  HTML     40K 
                intangible assets subject to amortization                        
                (Details)                                                        
67: R55         Investments (Details)                               HTML     49K 
68: R56         Employee Benefit Plans - Schedule of net periodic   HTML     45K 
                costs (Details)                                                  
69: R57         Employee Benefit Plans - Narrative (Details)        HTML     30K 
70: R58         Stock-Based Compensation (Details)                  HTML     39K 
71: R59         Treasury Stock - Schedule of repurchase of common   HTML     37K 
                stock (Details)                                                  
72: R60         Accumulated Other Comprehensive Income (Loss) -     HTML     75K 
                Schedule of AOCI Activity (Details)                              
73: R61         Accumulated Other Comprehensive Income (Loss) -     HTML     45K 
                Reclassification out of AOCI (Details)                           
74: R62         Income Taxes and Other Taxes (Details)              HTML     37K 
75: R63         Derivatives and Hedging (Details)                   HTML     28K 
76: R64         Other Accrued Expenses - Schedule of accrued        HTML     37K 
                expenses (Details)                                               
77: R65         Related Party Disclosures (Details)                 HTML     36K 
78: R66         Subsequent Events (Details)                         HTML     28K 
81: XML         IDEA XML File -- Filing Summary                      XML    144K 
79: XML         XBRL Instance -- schl-20220228_htm                   XML   2.34M 
80: EXCEL       IDEA Workbook of Financial Reports                  XLSX     92K 
 9: EX-101.CAL  XBRL Calculations -- schl-20220228_cal               XML    172K 
10: EX-101.DEF  XBRL Definitions -- schl-20220228_def                XML    561K 
11: EX-101.LAB  XBRL Labels -- schl-20220228_lab                     XML   1.47M 
12: EX-101.PRE  XBRL Presentations -- schl-20220228_pre              XML    849K 
 8: EX-101.SCH  XBRL Schema -- schl-20220228                         XSD    165K 
82: JSON        XBRL Instance as JSON Data -- MetaLinks              375±   519K 
83: ZIP         XBRL Zipped Folder -- 0000866729-22-000010-xbrl      Zip    339K 


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 10.1
SHARE REPURCHASE AGREEMENT

This SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 12, 2022 by and between Scholastic Corporation, a Delaware corporation (the “Company”), and the Preliminary co-Executors of the Estate of M. Richard Robinson, Jr., (“Stockholder”).

RECITAL

WHEREAS, the Stockholder has offered to sell to the Company up to 300,000 shares of the Company's common stock, par value, $.01 per share ("Common Shares") at the price per share determined in accordance with Section 1 below, including the formula provided in Schedule A, (the "Transaction"); and

    WHEREAS, the Company has a share repurchase program pursuant to which up to approximately $63 million may be employed to repurchase Common Shares in the open market or through privately negotiated transactions; and

WHEREAS, the Stockholder is a related party vis a vis the Company because the two Preliminary co-Executors are executive officers and, in one case, a director of the Company; and

    WHEREAS, because of the related party aspects of the Transaction, the Company referred consideration of the matter to the Company's Audit Committee (the "Committee"); and

    WHEREAS, the Committee approved the Transaction (subject to approval by all of the disinterested members of the full Board of Directors) after considering, among other factors, the following: (i) the Company's capacity to execute the Transaction under its existing share repurchase program, (ii) the limited amount of Common Shares that the Company has been able to repurchase subject to the Rule 10b-18 safe harbor guidelines since it restarted purchases under its share repurchase program, (iii) the Company's current share repurchase goals, (iv) the Company's available cash position, (v) the Company's desire to reverse the impact of dilutive issuance of Common Shares from compensatory programs, (vi) the ability to execute the Transaction without the need for the Company to pay brokerage fees on the shares to be repurchased, (vii) information obtained from an independent financial adviser selected by the Committee and (viii) the material terms of an indicative offer made to the Stockholder for a share purchase by an independent third party financial institution; and

    WHEREAS, the Board of Directors (without the participation of the interested director) approved the Transaction of the basis of the Committee's recommendation.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto agree as follows:

1. Repurchase. Subject to the terms and conditions set forth in this Agreement, Stockholder hereby agrees to sell, assign, transfer, convey and deliver all its right, title and interest in and to 300,000 Common Shares (the "Repurchased Shares") to the Company free and clear of all liens, encumbrances, pledges, options, warrants, rights of first refusal, claims, charges, restrictions or claims or rights of third parties of any kind or nature (collectively, “Liens”), other than the lien of UBS Bank USA (the "UBS Lien") which will be released in connection with the repayment of a loan ("Stockholder Loan"), constituting an obligation of the Stockholder, out of the proceeds of this Transaction. The Company hereby agrees to repurchase and accept delivery of the Repurchased Shares in exchange for the payment of the Aggregate Cash Consideration, which is defined as the amount determined by multiplying (A) 300,000 by (B) the price per share number determined as set forth on Schedule A. Stockholder hereby acknowledges and agrees that receipt of the Aggregate Cash Consideration shall constitute complete
1



satisfaction of all obligations or any other sums due to such Stockholder with respect to repurchase of the Repurchased Shares.

2. Closing. The closing of the repurchase provided for herein (the “Closing”) shall take place on January 20, 2022 (or such other date as the parties may mutually agree) at the offices of the Company located at 557 Broadway, New York, New York 10012 (or at such other place upon which the parties hereto may mutually agree). At the Closing, the following shall occur:

a. Stockholder Deliveries. The Repurchased Shares are credited to or otherwise held in a securities account maintained by Stockholder at UBS Bank USA and are to be delivered through the facilities of The Depository Trust Company. The Stockholder shall take such actions necessary to provide appropriate instruction to UBS Bank USA to effect the transfer of the Repurchased Shares from Stockholder’s account to the account at a financial institution designated by the Company for the receipt of the Repurchased Shares so transferred in Schedule B to this Agreement. In connection with any account to which the Repurchased Shares are credited or otherwise held, Stockholder shall execute and deliver such other and further documents or instruments necessary, in the reasonable opinion of the Company, to effect a legally valid transfer to the Company hereunder. Substantially concurrently with the Closing, Stockholder will also provide evidence satisfactory to the Company that the Stockholder Loan has been repaid in full and that the UBS Lien has been released from the Repurchased Shares.

b. Company Deliveries. The Company shall deliver by wire transfer in immediately available funds out of the proceeds of the Aggregate Cash Consideration: (i) to UBS Bank USA to the account listed in Schedule C hereto that has been designated by UBS Bank USA in the amount set forth in Schedule C and (ii) the remainder of the Aggregate Cash Consideration to the account listed in Schedule D hereto that has been designated by Stockholder.

 3. No Further Ownership Interest. From and after the Closing, Stockholder shall have no further right or title to or interest in the Repurchased Shares or any dividends, distributions, equity interests or other rights in respect thereof.

 4. Representations and Warranties of Stockholder. Stockholder represents and warrants to the Company as follows:

a. Title to Shares. As of the date hereof, Stockholder owns good and marketable title to the Repurchased Shares and such Repurchased Shares are free and clear of all Liens, other than the UBS Lien. Except for this Agreement, Stockholder has not entered into or agreed to be bound by any other arrangements or agreements of any kind with any other Person with respect to the Repurchased Shares, including, but not limited to, arrangements or agreements with respect to the acquisition or disposition thereof or any interest therein or the voting of any such Repurchased Shares.

b. Binding Effect. This Agreement is a legal, valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws relating to or affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law).

c. Governmental Authorization; Third Party Consent. No approval, consent, compliance, exemption, authorization, or other action by or notice to, or filing with, any governmental authority or any other person in respect of any requirements of law is necessary or required by Stockholder in connection with the execution, delivery or performance by Stockholder of this Agreement, except for such approval, consent, compliance, exemption, authorization, or other action which, if not obtained or made, would not reasonably be likely to prevent or materially delay Stockholder from performing its obligations under this Agreement in all material respects.
2




d. Brokers or Finders. Stockholder has not employed or entered into any agreement with, nor is Stockholder subject to, any valid claim of any broker, finder, financial advisor, consultant, or other intermediary in connection with the transactions contemplated by this Agreement who might be entitled to a fee or commission in connection with such transactions.

e. Legal Proceedings. There are no legal proceedings pending or, to the knowledge of Stockholder, threatened, to which Stockholder is or may be a party, that (i) challenge the validity or enforceability of Stockholder’s obligations under this Agreement or (ii) seek to prevent, delay or otherwise would reasonably be expected to materially adversely affect the consummation by Stockholder of the transactions contemplated hereby.

f. Material Non-Public Information. Stockholder acknowledges and agrees that the Company may possess material, nonpublic information that has not been disclosed by the Company. Stockholder hereby further acknowledges that it is entering into this Agreement and the transactions contemplated hereby notwithstanding this disparity of information, if any, and waives any claims related to this information disparity.

g. Absence of Trading. Stockholder has not transacted any purchases or sales of Common Shares (or any related securities) any time after December 31, 2021.

5. Representations and Warranties of the Company. The Company represents and warrants to Stockholder as follows:

a. Authority; Binding Effect. The Company is a corporation validly existing and in good standing under the laws of the State of Delaware and has all requisite power and authority and has taken all necessary action required for the due authorization, execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated herein. This Agreement is a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws relating to or affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law).

b. No Violation. Neither the execution and delivery of this Agreement by the Company, nor the repurchase of the Repurchased Shares owned by Stockholder pursuant to this Agreement, will (i) result in a breach of its organizational documents, (ii) result in a default (or give rise to any right of termination, cancellation or acceleration) under any of the terms, conditions or provisions of any material agreement, lease or other instrument or obligation to which the Company is a party, except for such defaults (or rights of termination, cancellation or acceleration) as to which requisite waivers or consents have been obtained and are in full force and effect or which would not impair the Company’s ability to consummate the transactions contemplated by this Agreement, or (iii) violate any order, writ, injunction or decree applicable to the Company or any of the Company’s material assets.

c. Governmental Authorization; Third Party Consent. No approval, consent, compliance, exemption, authorization, or other action by or notice to, or filing with, any governmental authority or any other person in respect of any requirements of law is necessary or required by the Company in connection with the execution, delivery or performance by the Company of this Agreement, except for such approval, consent, compliance, exemption, authorization, or other action which, if not obtained or made, would not reasonably be likely to prevent or materially delay the Company from performing its obligations under this Agreement in all material respects.

3



d. Brokers or Finders. Except for the Company's engagement of an investment banking firm identified to the Stockholder, as an advisor in connection with the transactions contemplated by this Agreement, the Company has not employed or entered into any agreement with, nor is the Company subject to, any valid claim of any broker, finder, consultant, financial advisor or other intermediary in connection with the transactions contemplated by this Agreement who might be entitled to a fee or commission in connection with such transactions.

e. Exchange Act Reports. The Company’s reports filed with the Securities and Exchange Commission (the “Commission”) pursuant to Section 13(a), 13(c) or 15(d) of the Securities Exchange Act of 1934, as amended, and any amendment or supplement thereto, did not, when filed with the Commission, and do not, as of the date hereof, contain an untrue statement of material fact or omit to state a material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.

 6. Affirmative Covenants.

(a)    The parties hereto acknowledge and agree that the Company shall submit to the Commission a report on Form 8-K disclosing the repurchase transaction following the Closing (the "Form 8-K"). Stockholder shall have the right to provide comments on the text of the Form 8-K prior to it being provided to the Commission.

(b)    Neither the parties hereto nor any of their related parties shall disclose the terms of this Agreement to any person, except as may be required by law or legal process (including any probate process applicable to the Stockholder) and except for any disclosure to UBS Bank USA that is reasonably necessary in connection with the release of the UBS Lien, the repayment of the Stockholder Loan and to facilitate delivery of the Repurchased Shares in connection with the Closing. The parties may, however, refer to the Form 8-K and its contents after it is submitted to the Commission.

(c)    Each party agrees that its representations and warranties shall be true and correct on the date of Closing.

     7. Miscellaneous.

a. Amendment. This Agreement may not be amended or waived in any respect except by a written agreement signed by the parties hereto.

b. Survival. Each of the representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing and continue in full force and effect in accordance with its terms, but is subject to all applicable statutes of limitation, statutes of repose and other similar defenses provided in law or equity.

c. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and shall supersede all previous negotiations, commitments, agreements and understandings (both oral and written) with respect to such subject matter.

d. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed counterpart of a signature page of this Agreement by facsimile transmission or electronic image scan shall be effective as delivery of a manually executed counterpart of this Agreement.

e. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.

4



f. Expenses. Each party shall bear its own expenses and fees in connection with the execution of this Agreement and the consummation of the transactions contemplated hereby.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]


5






IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above.
     
 SCHOLASTIC CORPORATION
 
 
 By:  /s/ Peter Warwick 
       Name:  Peter Warwick 
       Title:  Chief Executive Officer 
 
 THE PRELIMINARY CO- EXECUTORS OF THE ESTATE OF M. RICHARD ROBINSON, JR.
 
 
 By:   
       Name:  Iole Lucchese 
       Title:  Preliminary Co-Executor  and Designated Scholastic Special Purpose Executor 
 

 


6



SCHEDULE A
PRICE DETERMINATION FORMULA


    The price per Common Share to be paid shall be the product of (i) 0.958 and (ii) the closing price of a Common Share of Scholastic as of the end of the regular trading session (4:00 p.m. EST) on January 12, 2022.

7



SCHEDULE B
COMPANY SECURITIES ACCOUNT INFORMATION

(Account name and address to which the repurchased shares shall be delivered)

Agent:         Computershare
Agent’s Address:    Newport Office Center VII
480 Washington Boulevard 29th Floor
Jersey City, New Jersey 07310
Attention: Mr. Cory McQuillen
Agent’s DTC No.:    50237
For Account:        Scholastic Corporation Treasury Account
Account No.:        redacted

8



SCHEDULE C

Name and Address of UBS Bank Account
(for receipt of repayment proceeds)

(To be provided)

9



SCHEDULE D

(Name and address of Stockholder account for any remaining proceeds)

(To be provided)
10


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:3/18/224
For Period end:2/28/22
1/20/228-K
1/12/22
12/31/21
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/21/23  Scholastic Corp.                  10-K        5/31/23  137:16M
11/28/22  Scholastic Corp.                  SC TO-I/A              2:94K  Scholastic Corp.                  Donnelley … Solutions/FA
11/23/22  Scholastic Corp.                  SC TO-I/A              2:88K  Scholastic Corp.                  Donnelley … Solutions/FA
10/25/22  Scholastic Corp.                  SC TO-I               10:1.2M Scholastic Corp.                  Donnelley … Solutions/FA
 7/22/22  Scholastic Corp.                  10-K        5/31/22  131:17M
Top
Filing Submission 0000866729-22-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 6:45:13.1pm ET